Targeting PKCa alleviates iron overload in diabetes and hemochromatosis through the inhibition of ferroportin

By sjmartinez • June 12, 2024

Banerjee S, Lu S, Jain A, Wang I, Tao H, Srinivasan S, Nemeth E, He P. Targeting PKCa alleviates iron overload in diabetes and hemochromatosis through the inhibition of ferroportin. Blood. 2024 Jun 11:blood.2024023829. doi: 10.1182/blood.2024023829. Epub ahead of print. PMID: 38861671.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial

Bishop CW, Ashfaq A, Choe J, Strugnell SA, Johnson LL, Norris KC, Sprague SM. Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism[...]

Social isolation and functional impairment trajectories in a diverse cohort of middle-aged and older adults in Northern California

Rojas-Saunero LP, Ikesu R, Zhou Y, Hayes-Larson E, Fong JO, Chen R, Posis AIB, Whitmer RA, Gilsanz P, Glymour MM, Torres JM, Kotwal AA, Mayeda[...]

Cognitive Function and Neurodegenerative Blood Biomarkers in an Aging Indian Population: Insights From LASI-DAD Wave 2

Rao AR, Pradhan R, Anwar M, Gupta A, Bhagwasia M, Nichols E, Gross AL, Thyagarajan B, Hu P, Crimmins EM, Dey AB, Lee J, Dey[...]